Experiment 635031

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismAesculus hippocastanum (HIPPOCASTANACEAE)
CitationALTER,VH:. (1973). ZUR MEDIKAMENTOSEN THERAPIE DER VARIKOSIS.. 49(27)
Amount utilized
Compound isolated
DiseaseA DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL ASSESSED THE EFFICACY OF THE STANDARDIZED EXTRACT FOR THE TREAMENT OF 131 PATIENST WITH CVI, AFTER TWO TREATMENT PERIODS OF 20 DAYS EACH. SYMPTOMATIC IMPROVEMENTS IN SKIN COLOR, VENOUS PROMINENCE, EDEMA, DERMATOSES, PAIN, ITCHING AND THE FEELING OF LEG HEAVINESS WERE OBSERVED IN PATIENTS TREATED WITH THE STADARDIZED EXTRACT (600 MG/DAY CORRESPONDING TO 100 MG/DAY OF AESCIN). A COMMERCIAL PRODUCT, VENOSTATIN, WAS USED.
Dose amount600.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractHYDRO-ALCOHOLIC EXT
GenderGIVEN TO BOTH SEXES